1 Week to Go to SMi’s 22nd Annual Superbugs & Superdrugs Conference
SMi Reports: Superbugs & Superdrugs conference taking place next week, will now be by remote access only.
London, United Kingdom, March 26, 2020 --(PR.com)-- With only 1 week remaining, the 22nd Annual Superbugs & Superdrugs Conference will reconvene on March 30 and 31, with remote access only. This year’s global focused two-day conference pharmaceutical is for industry professionals looking to gain an in-depth knowledge of the scientific, economic, and regulatory challenges facing the critical global issue of antibiotic resistance.
Interested parties are urged to register at: www.superbugssuperdrugs.com/PRcom6
The conference will consist of an impressive 15+ speaker line-up from well-established big pharma, academia and government organisations, where delegates can hear their extensive experiences and knowledge on the critical subject of growing antibiotic resistance.
The two-day conference is co-chaired by Cara Cassino, CMO, Contrafect and Michael Dawson, Director, Mike Dawson Antimicrobial Research Consultancy.
Featured 2020 Experts and Remote Presentations:
Exploring new classes of non-antibiotic antibacterial proteins: Colicins and Colicin-like Bacteriocins
Yuri Gleba, Professor, Founder, Nomad Bioscience
Update on the UK project looking at novel value assessment and reimbursement for novel antimicrobials
Colm Leonard, Consultant Clinical Adviser/Consultant Thoracic Physician/Honorary Professor of Medicine, NICE & Machester University NHS Foundation Trust
The BARDA Antibacterials Program
Brian Tse, Health Scientist, Biomedical Advanced Research and Development Authority (BARDA)
Discovery of Dabocins, a novel class of non-ß-lactam PBP inhibitors
Francois Moreau, Scientific Director, Mutabilis S A
Evaluating the utility of machine learning and AI in antibiotic drug discovery
Paul Finn, CEO, Oxford Drug Design
The conference with remote access is available for registration for only £999. Register at www.superbugssuperdrugs.com/PRcom6
The event is sponsored by Scynexis.
For sponsorship enquiries, contact Alia Malick on +44 (0)20 7827 6164 or amalick@smi-online.co.uk
For registration information, contact Dylan Brohm at dbrohm@smi-online.co.uk or call on +44 (0) 207 827 1024.
For media enquiries, contact Simi Sapal on +44 (0) 20 7827 6000 or ssapal@smi-online.co.uk
Superbugs & Superdrugs 2020
Conference: 30-31 March 2020
Remote Access Only
www.superbugssuperdrugs.com/PRcom6
#SMiBugs
About SMi Group:
Established since 1993, the SMi Group is a global event-production company that specializes in Business-to-Business Conferences, Workshops, Masterclasses and online Communities. We create and deliver events in the Defence, Security, Energy, Utilities, Finance and Pharmaceutical industries. We pride ourselves on having access to the world’s most forward-thinking opinion leaders and visionaries, allowing us to bring our communities together to Learn, Engage, Share and Network. More information can be found at http://www.smi-online.co.uk
Interested parties are urged to register at: www.superbugssuperdrugs.com/PRcom6
The conference will consist of an impressive 15+ speaker line-up from well-established big pharma, academia and government organisations, where delegates can hear their extensive experiences and knowledge on the critical subject of growing antibiotic resistance.
The two-day conference is co-chaired by Cara Cassino, CMO, Contrafect and Michael Dawson, Director, Mike Dawson Antimicrobial Research Consultancy.
Featured 2020 Experts and Remote Presentations:
Exploring new classes of non-antibiotic antibacterial proteins: Colicins and Colicin-like Bacteriocins
Yuri Gleba, Professor, Founder, Nomad Bioscience
Update on the UK project looking at novel value assessment and reimbursement for novel antimicrobials
Colm Leonard, Consultant Clinical Adviser/Consultant Thoracic Physician/Honorary Professor of Medicine, NICE & Machester University NHS Foundation Trust
The BARDA Antibacterials Program
Brian Tse, Health Scientist, Biomedical Advanced Research and Development Authority (BARDA)
Discovery of Dabocins, a novel class of non-ß-lactam PBP inhibitors
Francois Moreau, Scientific Director, Mutabilis S A
Evaluating the utility of machine learning and AI in antibiotic drug discovery
Paul Finn, CEO, Oxford Drug Design
The conference with remote access is available for registration for only £999. Register at www.superbugssuperdrugs.com/PRcom6
The event is sponsored by Scynexis.
For sponsorship enquiries, contact Alia Malick on +44 (0)20 7827 6164 or amalick@smi-online.co.uk
For registration information, contact Dylan Brohm at dbrohm@smi-online.co.uk or call on +44 (0) 207 827 1024.
For media enquiries, contact Simi Sapal on +44 (0) 20 7827 6000 or ssapal@smi-online.co.uk
Superbugs & Superdrugs 2020
Conference: 30-31 March 2020
Remote Access Only
www.superbugssuperdrugs.com/PRcom6
#SMiBugs
About SMi Group:
Established since 1993, the SMi Group is a global event-production company that specializes in Business-to-Business Conferences, Workshops, Masterclasses and online Communities. We create and deliver events in the Defence, Security, Energy, Utilities, Finance and Pharmaceutical industries. We pride ourselves on having access to the world’s most forward-thinking opinion leaders and visionaries, allowing us to bring our communities together to Learn, Engage, Share and Network. More information can be found at http://www.smi-online.co.uk
Contact
SMi Group
Simi Sapal
+44 (0) 20 7827 6088
http://www.superbugssuperdrugs.com/PRcom6
Contact
Simi Sapal
+44 (0) 20 7827 6088
http://www.superbugssuperdrugs.com/PRcom6
Categories